SCHEMBL4546972

SCHEMBL4546972

Cc1cccc(-c2cccc(-c3cc(-c4cccc(C)c4)nc(-c4ccccc4)n3)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.53
MEN1 O00255 6/20 0.51
KMT2A Q03164 6/20 0.51
HPGD P15428 5/20 0.51
MAPT P10636 5/20 0.51
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 3/20 0.51
LMNA P02545 2/20 0.51
GLA P06280 1/20 0.51
DPP4 P27487 1/20 0.51
NTSR1 P30989 1/20 0.50
IDO1 P14902 1/20 0.50
METAP2 P50579 1/20 0.50
NR1I3 Q14994 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.48
DHODH Q02127 1/20 0.47
XDH P47989 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
NPC1 O15118 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10128354 1.00 RAB9A (0.53) RAB9AMEN1KMT2AHPGDMAPT
SCHEMBL4546922 1.00 RAB9A (0.53) RAB9AMEN1KMT2AHPGDMAPT
SCHEMBL4546911 1.00 RAB9A (0.53) RAB9AMEN1KMT2AHPGDMAPT
SCHEMBL12936803 0.98 MEN1 (0.54) RAB9AMEN1KMT2AHPGDMAPT
SCHEMBL18731951 0.98 RAB9A (0.51) RAB9AMEN1KMT2AHPGDMAPT
SCHEMBL4546921 0.96 RAB9A (0.50) RAB9AMEN1KMT2AHPGDMAPT
SCHEMBL4546907 0.96 RAB9A (0.56) RAB9AMEN1KMT2AHPGDMAPT
SCHEMBL22308562 0.95 MEN1 (0.56) RAB9AMEN1KMT2AHPGDMAPT
SCHEMBL10128459 0.95 MEN1 (0.51) RAB9AMEN1KMT2AHPGDMAPT
SCHEMBL22373655 0.95 RAB9A (0.56) RAB9AMEN1KMT2AHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178215-B2 Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound PIONEER CORPORATION (JP) 2012-05-15 US disclosed
US-20090236973-A1 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT PIONEER CORPORATION (JO) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090236973-A1 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT SLCO4C1, SLCO2A1, SLCO2B1 RAB9A 1478/4885MEN1 1984/4885KMT2A 1753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.